Tubulis (Germany)

Startseite - Tubulis

Tubulis is now part of Gilead Sciences www.gilead.com NEWS April 21 Tubulis to Present Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-resistant Ovarian Cancer in Rapid Oral Presentation at ASCO 2026 April 07 Gilead to Acquire Tubulis Adding Potentially Best-In-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline January 27 […]